Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...

Brain metastases from prostate cancer (PC) seem to be more frequent ... be further divided into epidural and subdural lesions. The symptoms of BMs are usually related to intracranial hypertension ...

New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

Cancer a life-threatening disease can spread or metastasise from its original location to other parts of the body The lungs ...

Unemployment Rate for Dec in Russia is 2.3%, unchanged from its last period. Unemployment Rate for Jan in Canada is 6.6%, ...

The US regulator has approved Nubeqa (darolutamide) in combination with docetaxel chemotherapy for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC), adding to its earlier ...

With a new treatment for prostate cancer in play, men with more aggressive forms of prostate cancer may have a more positive ...

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...